1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Pancreatic Beta-Cell Protection Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Stem Cell Based 1.2.3 Gene Therapies 1.2.4 RNA Based Therapies 1.2.5 Monoclonal Antibodies (MAbs) 1.2.6 Phytotherapy 1.3 Market by Application 1.3.1 Global Pancreatic Beta-Cell Protection Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Medical Research Laboratory 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Pancreatic Beta-Cell Protection Market Perspective (2016-2027) 2.2 Pancreatic Beta-Cell Protection Growth Trends by Regions 2.2.1 Pancreatic Beta-Cell Protection Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Pancreatic Beta-Cell Protection Historic Market Share by Regions (2016-2021) 2.2.3 Pancreatic Beta-Cell Protection Forecasted Market Size by Regions (2022-2027) 2.3 Pancreatic Beta-Cell Protection Industry Dynamic 2.3.1 Pancreatic Beta-Cell Protection Market Trends 2.3.2 Pancreatic Beta-Cell Protection Market Drivers 2.3.3 Pancreatic Beta-Cell Protection Market Challenges 2.3.4 Pancreatic Beta-Cell Protection Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Pancreatic Beta-Cell Protection Players by Revenue 3.1.1 Global Top Pancreatic Beta-Cell Protection Players by Revenue (2016-2021) 3.1.2 Global Pancreatic Beta-Cell Protection Revenue Market Share by Players (2016-2021) 3.2 Global Pancreatic Beta-Cell Protection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Pancreatic Beta-Cell Protection Revenue 3.4 Global Pancreatic Beta-Cell Protection Market Concentration Ratio 3.4.1 Global Pancreatic Beta-Cell Protection Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Pancreatic Beta-Cell Protection Revenue in 2020 3.5 Pancreatic Beta-Cell Protection Key Players Head office and Area Served 3.6 Key Players Pancreatic Beta-Cell Protection Product Solution and Service 3.7 Date of Enter into Pancreatic Beta-Cell Protection Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Pancreatic Beta-Cell Protection Breakdown Data by Type 4.1 Global Pancreatic Beta-Cell Protection Historic Market Size by Type (2016-2021) 4.2 Global Pancreatic Beta-Cell Protection Forecasted Market Size by Type (2022-2027) 5 Pancreatic Beta-Cell Protection Breakdown Data by Application 5.1 Global Pancreatic Beta-Cell Protection Historic Market Size by Application (2016-2021) 5.2 Global Pancreatic Beta-Cell Protection Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Pancreatic Beta-Cell Protection Market Size (2016-2027) 6.2 North America Pancreatic Beta-Cell Protection Market Size by Type 6.2.1 North America Pancreatic Beta-Cell Protection Market Size by Type (2016-2021) 6.2.2 North America Pancreatic Beta-Cell Protection Market Size by Type (2022-2027) 6.2.3 North America Pancreatic Beta-Cell Protection Market Size by Type (2016-2027) 6.3 North America Pancreatic Beta-Cell Protection Market Size by Application 6.3.1 North America Pancreatic Beta-Cell Protection Market Size by Application (2016-2021) 6.3.2 North America Pancreatic Beta-Cell Protection Market Size by Application (2022-2027) 6.3.3 North America Pancreatic Beta-Cell Protection Market Size by Application (2016-2027) 6.4 North America Pancreatic Beta-Cell Protection Market Size by Country 6.4.1 North America Pancreatic Beta-Cell Protection Market Size by Country (2016-2021) 6.4.2 North America Pancreatic Beta-Cell Protection Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Pancreatic Beta-Cell Protection Market Size (2016-2027) 7.2 Europe Pancreatic Beta-Cell Protection Market Size by Type 7.2.1 Europe Pancreatic Beta-Cell Protection Market Size by Type (2016-2021) 7.2.2 Europe Pancreatic Beta-Cell Protection Market Size by Type (2022-2027) 7.2.3 Europe Pancreatic Beta-Cell Protection Market Size by Type (2016-2027) 7.3 Europe Pancreatic Beta-Cell Protection Market Size by Application 7.3.1 Europe Pancreatic Beta-Cell Protection Market Size by Application (2016-2021) 7.3.2 Europe Pancreatic Beta-Cell Protection Market Size by Application (2022-2027) 7.3.3 Europe Pancreatic Beta-Cell Protection Market Size by Application (2016-2027) 7.4 Europe Pancreatic Beta-Cell Protection Market Size by Country 7.4.1 Europe Pancreatic Beta-Cell Protection Market Size by Country (2016-2021) 7.4.2 Europe Pancreatic Beta-Cell Protection Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Pancreatic Beta-Cell Protection Market Size (2016-2027) 8.2 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Type 8.2.1 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Type (2016-2027) 8.3 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Application 8.3.1 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Application (2016-2027) 8.4 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region 8.4.1 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Pancreatic Beta-Cell Protection Market Size (2016-2027) 9.2 Latin America Pancreatic Beta-Cell Protection Market Size by Type 9.2.1 Latin America Pancreatic Beta-Cell Protection Market Size by Type (2016-2021) 9.2.2 Latin America Pancreatic Beta-Cell Protection Market Size by Type (2022-2027) 9.2.3 Latin America Pancreatic Beta-Cell Protection Market Size by Type (2016-2027) 9.3 Latin America Pancreatic Beta-Cell Protection Market Size by Application 9.3.1 Latin America Pancreatic Beta-Cell Protection Market Size by Application (2016-2021) 9.3.2 Latin America Pancreatic Beta-Cell Protection Market Size by Application (2022-2027) 9.3.3 Latin America Pancreatic Beta-Cell Protection Market Size by Application (2016-2027) 9.4 Latin America Pancreatic Beta-Cell Protection Market Size by Country 9.4.1 Latin America Pancreatic Beta-Cell Protection Market Size by Country (2016-2021) 9.4.2 Latin America Pancreatic Beta-Cell Protection Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Pancreatic Beta-Cell Protection Market Size (2016-2027) 10.2 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type 10.2.1 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type (2016-2027) 10.3 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application 10.3.1 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application (2016-2027) 10.4 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country 10.4.1 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 ViaCyte 11.1.1 ViaCyte Company Details 11.1.2 ViaCyte Business Overview 11.1.3 ViaCyte Pancreatic Beta-Cell Protection Introduction 11.1.4 ViaCyte Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) 11.1.5 ViaCyte Recent Development 11.2 PharmaCyte Biotech 11.2.1 PharmaCyte Biotech Company Details 11.2.2 PharmaCyte Biotech Business Overview 11.2.3 PharmaCyte Biotech Pancreatic Beta-Cell Protection Introduction 11.2.4 PharmaCyte Biotech Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) 11.2.5 PharmaCyte Biotech Recent Development 11.3 Boehringer Ingelheim 11.3.1 Boehringer Ingelheim Company Details 11.3.2 Boehringer Ingelheim Business Overview 11.3.3 Boehringer Ingelheim Pancreatic Beta-Cell Protection Introduction 11.3.4 Boehringer Ingelheim Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) 11.3.5 Boehringer Ingelheim Recent Development 11.4 GalaxoSmithKline 11.4.1 GalaxoSmithKline Company Details 11.4.2 GalaxoSmithKline Business Overview 11.4.3 GalaxoSmithKline Pancreatic Beta-Cell Protection Introduction 11.4.4 GalaxoSmithKline Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) 11.4.5 GalaxoSmithKline Recent Development 11.5 Beta-Cell NV 11.5.1 Beta-Cell NV Company Details 11.5.2 Beta-Cell NV Business Overview 11.5.3 Beta-Cell NV Pancreatic Beta-Cell Protection Introduction 11.5.4 Beta-Cell NV Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) 11.5.5 Beta-Cell NV Recent Development 11.6 Novartis 11.6.1 Novartis Company Details 11.6.2 Novartis Business Overview 11.6.3 Novartis Pancreatic Beta-Cell Protection Introduction 11.6.4 Novartis Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) 11.6.5 Novartis Recent Development 11.7 Janssen Research & Development 11.7.1 Janssen Research & Development Company Details 11.7.2 Janssen Research & Development Business Overview 11.7.3 Janssen Research & Development Pancreatic Beta-Cell Protection Introduction 11.7.4 Janssen Research & Development Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) 11.7.5 Janssen Research & Development Recent Development 11.8 Pfizer Inc 11.8.1 Pfizer Inc Company Details 11.8.2 Pfizer Inc Business Overview 11.8.3 Pfizer Inc Pancreatic Beta-Cell Protection Introduction 11.8.4 Pfizer Inc Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) 11.8.5 Pfizer Inc Recent Development 11.9 BioLineRx 11.9.1 BioLineRx Company Details 11.9.2 BioLineRx Business Overview 11.9.3 BioLineRx Pancreatic Beta-Cell Protection Introduction 11.9.4 BioLineRx Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) 11.9.5 BioLineRx Recent Development 11.10 Genentech 11.10.1 Genentech Company Details 11.10.2 Genentech Business Overview 11.10.3 Genentech Pancreatic Beta-Cell Protection Introduction 11.10.4 Genentech Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) 11.10.5 Genentech Recent Development 11.11 Novo Nordisk 11.11.1 Novo Nordisk Company Details 11.11.2 Novo Nordisk Business Overview 11.11.3 Novo Nordisk Pancreatic Beta-Cell Protection Introduction 11.11.4 Novo Nordisk Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) 11.11.5 Novo Nordisk Recent Development 11.12 Sanofi 11.12.1 Sanofi Company Details 11.12.2 Sanofi Business Overview 11.12.3 Sanofi Pancreatic Beta-Cell Protection Introduction 11.12.4 Sanofi Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) 11.12.5 Sanofi Recent Development 11.13 Osiris Therapeutics 11.13.1 Osiris Therapeutics Company Details 11.13.2 Osiris Therapeutics Business Overview 11.13.3 Osiris Therapeutics Pancreatic Beta-Cell Protection Introduction 11.13.4 Osiris Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) 11.13.5 Osiris Therapeutics Recent Development 11.14 Beta-O2 Technologies Ltd 11.14.1 Beta-O2 Technologies Ltd Company Details 11.14.2 Beta-O2 Technologies Ltd Business Overview 11.14.3 Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Introduction 11.14.4 Beta-O2 Technologies Ltd Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) 11.14.5 Beta-O2 Technologies Ltd Recent Development 11.15 Transition Therapeutics 11.15.1 Transition Therapeutics Company Details 11.15.2 Transition Therapeutics Business Overview 11.15.3 Transition Therapeutics Pancreatic Beta-Cell Protection Introduction 11.15.4 Transition Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) 11.15.5 Transition Therapeutics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Pancreatic Beta-Cell Protection Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Stem Cell Based Table 3. Key Players of Gene Therapies Table 4. Key Players of RNA Based Therapies Table 5. Key Players of Monoclonal Antibodies (MAbs) Table 6. Key Players of Phytotherapy Table 7. Global Pancreatic Beta-Cell Protection Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Pancreatic Beta-Cell Protection Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Pancreatic Beta-Cell Protection Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Pancreatic Beta-Cell Protection Market Share by Regions (2016-2021) Table 11. Global Pancreatic Beta-Cell Protection Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Pancreatic Beta-Cell Protection Market Share by Regions (2022-2027) Table 13. Pancreatic Beta-Cell Protection Market Trends Table 14. Pancreatic Beta-Cell Protection Market Drivers Table 15. Pancreatic Beta-Cell Protection Market Challenges Table 16. Pancreatic Beta-Cell Protection Market Restraints Table 17. Global Pancreatic Beta-Cell Protection Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Pancreatic Beta-Cell Protection Market Share by Players (2016-2021) Table 19. Global Top Pancreatic Beta-Cell Protection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pancreatic Beta-Cell Protection as of 2020) Table 20. Ranking of Global Top Pancreatic Beta-Cell Protection Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Pancreatic Beta-Cell Protection Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Pancreatic Beta-Cell Protection Product Solution and Service Table 24. Date of Enter into Pancreatic Beta-Cell Protection Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Pancreatic Beta-Cell Protection Market Size by Type (2016-2021) (US$ Million) Table 27. Global Pancreatic Beta-Cell Protection Revenue Market Share by Type (2016-2021) Table 28. Global Pancreatic Beta-Cell Protection Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Pancreatic Beta-Cell Protection Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Pancreatic Beta-Cell Protection Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Pancreatic Beta-Cell Protection Revenue Market Share by Application (2016-2021) Table 32. Global Pancreatic Beta-Cell Protection Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Pancreatic Beta-Cell Protection Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Pancreatic Beta-Cell Protection Market Size by Type (2016-2021) (US$ Million) Table 35. North America Pancreatic Beta-Cell Protection Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Pancreatic Beta-Cell Protection Market Size by Application (2016-2021) (US$ Million) Table 37. North America Pancreatic Beta-Cell Protection Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Pancreatic Beta-Cell Protection Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Pancreatic Beta-Cell Protection Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Pancreatic Beta-Cell Protection Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Pancreatic Beta-Cell Protection Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Pancreatic Beta-Cell Protection Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Pancreatic Beta-Cell Protection Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Pancreatic Beta-Cell Protection Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Pancreatic Beta-Cell Protection Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Pancreatic Beta-Cell Protection Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Pancreatic Beta-Cell Protection Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Pancreatic Beta-Cell Protection Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Pancreatic Beta-Cell Protection Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Pancreatic Beta-Cell Protection Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Pancreatic Beta-Cell Protection Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country (2022-2027) & (US$ Million) Table 64. ViaCyte Company Details Table 65. ViaCyte Business Overview Table 66. ViaCyte Pancreatic Beta-Cell Protection Product Table 67. ViaCyte Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million) Table 68. ViaCyte Recent Development Table 69. PharmaCyte Biotech Company Details Table 70. PharmaCyte Biotech Business Overview Table 71. PharmaCyte Biotech Pancreatic Beta-Cell Protection Product Table 72. PharmaCyte Biotech Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million) Table 73. PharmaCyte Biotech Recent Development Table 74. Boehringer Ingelheim Company Details Table 75. Boehringer Ingelheim Business Overview Table 76. Boehringer Ingelheim Pancreatic Beta-Cell Protection Product Table 77. Boehringer Ingelheim Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million) Table 78. Boehringer Ingelheim Recent Development Table 79. GalaxoSmithKline Company Details Table 80. GalaxoSmithKline Business Overview Table 81. GalaxoSmithKline Pancreatic Beta-Cell Protection Product Table 82. GalaxoSmithKline Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million) Table 83. GalaxoSmithKline Recent Development Table 84. Beta-Cell NV Company Details Table 85. Beta-Cell NV Business Overview Table 86. Beta-Cell NV Pancreatic Beta-Cell Protection Product Table 87. Beta-Cell NV Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million) Table 88. Beta-Cell NV Recent Development Table 89. Novartis Company Details Table 90. Novartis Business Overview Table 91. Novartis Pancreatic Beta-Cell Protection Product Table 92. Novartis Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million) Table 93. Novartis Recent Development Table 94. Janssen Research & Development Company Details Table 95. Janssen Research & Development Business Overview Table 96. Janssen Research & Development Pancreatic Beta-Cell Protection Product Table 97. Janssen Research & Development Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million) Table 98. Janssen Research & Development Recent Development Table 99. Pfizer Inc Company Details Table 100. Pfizer Inc Business Overview Table 101. Pfizer Inc Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million) Table 102. Pfizer Inc Recent Development Table 103. BioLineRx Company Details Table 104. BioLineRx Business Overview Table 105. BioLineRx Pancreatic Beta-Cell Protection Product Table 106. BioLineRx Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million) Table 107. BioLineRx Recent Development Table 108. Genentech Company Details Table 109. Genentech Business Overview Table 110. Genentech Pancreatic Beta-Cell Protection Product Table 111. Genentech Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million) Table 112. Genentech Recent Development Table 113. Novo Nordisk Company Details Table 114. Novo Nordisk Business Overview Table 115. Novo Nordisk Pancreatic Beta-Cell Protection Product Table 116. Novo Nordisk Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million) Table 117. Novo Nordisk Recent Development Table 118. Sanofi Company Details Table 119. Sanofi Business Overview Table 120. Sanofi Pancreatic Beta-Cell Protection Product Table 121. Sanofi Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million) Table 122. Sanofi Recent Development Table 123. Osiris Therapeutics Company Details Table 124. Osiris Therapeutics Business Overview Table 125. Osiris Therapeutics Pancreatic Beta-Cell Protection Product Table 126. Osiris Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million) Table 127. Osiris Therapeutics Recent Development Table 128. Beta-O2 Technologies Ltd Company Details Table 129. Beta-O2 Technologies Ltd Business Overview Table 130. Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Product Table 131. Beta-O2 Technologies Ltd Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million) Table 132. Beta-O2 Technologies Ltd Recent Development Table 133. Transition Therapeutics Company Details Table 134. Transition Therapeutics Business Overview Table 135. Transition Therapeutics Pancreatic Beta-Cell Protection Product Table 136. Transition Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million) Table 137. Transition Therapeutics Recent Development Table 138. Research Programs/Design for This Report Table 139. Key Data Information from Secondary Sources Table 140. Key Data Information from Primary Sources List of Figures Figure 1. Global Pancreatic Beta-Cell Protection Market Share by Type: 2020 VS 2027 Figure 2. Stem Cell Based Features Figure 3. Gene Therapies Features Figure 4. RNA Based Therapies Features Figure 5. Monoclonal Antibodies (MAbs) Features Figure 6. Phytotherapy Features Figure 7. Global Pancreatic Beta-Cell Protection Market Share by Application: 2020 VS 2027 Figure 8. Hospital Case Studies Figure 9. Medical Research Laboratory Case Studies Figure 10. Others Case Studies Figure 11. Pancreatic Beta-Cell Protection Report Years Considered Figure 12. Global Pancreatic Beta-Cell Protection Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Pancreatic Beta-Cell Protection Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Pancreatic Beta-Cell Protection Market Share by Regions: 2020 VS 2027 Figure 15. Global Pancreatic Beta-Cell Protection Market Share by Regions (2022-2027) Figure 16. Global Pancreatic Beta-Cell Protection Market Share by Players in 2020 Figure 17. Global Top Pancreatic Beta-Cell Protection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pancreatic Beta-Cell Protection as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Pancreatic Beta-Cell Protection Revenue in 2020 Figure 19. Global Pancreatic Beta-Cell Protection Revenue Market Share by Type (2016-2021) Figure 20. Global Pancreatic Beta-Cell Protection Revenue Market Share by Type (2022-2027) Figure 21. North America Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Pancreatic Beta-Cell Protection Market Share by Type (2016-2027) Figure 23. North America Pancreatic Beta-Cell Protection Market Share by Application (2016-2027) Figure 24. North America Pancreatic Beta-Cell Protection Market Share by Country (2016-2027) Figure 25. United States Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Pancreatic Beta-Cell Protection Market Share by Type (2016-2027) Figure 29. Europe Pancreatic Beta-Cell Protection Market Share by Application (2016-2027) Figure 30. Europe Pancreatic Beta-Cell Protection Market Share by Country (2016-2027) Figure 31. Germany Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Pancreatic Beta-Cell Protection Market Share by Type (2016-2027) Figure 39. Asia-Pacific Pancreatic Beta-Cell Protection Market Share by Application (2016-2027) Figure 40. Asia-Pacific Pancreatic Beta-Cell Protection Market Share by Region (2016-2027) Figure 41. China Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Pancreatic Beta-Cell Protection Market Share by Type (2016-2027) Figure 49. Latin America Pancreatic Beta-Cell Protection Market Share by Application (2016-2027) Figure 50. Latin America Pancreatic Beta-Cell Protection Market Share by Country (2016-2027) Figure 51. Mexico Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Pancreatic Beta-Cell Protection Market Share by Type (2016-2027) Figure 55. Middle East & Africa Pancreatic Beta-Cell Protection Market Share by Application (2016-2027) Figure 56. Middle East & Africa Pancreatic Beta-Cell Protection Market Share by Country (2016-2027) Figure 57. Turkey Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. ViaCyte Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021) Figure 61. PharmaCyte Biotech Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021) Figure 62. Boehringer Ingelheim Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021) Figure 63. GalaxoSmithKline Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021) Figure 64. Beta-Cell NV Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021) Figure 65. Novartis Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021) Figure 66. Janssen Research & Development Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021) Figure 67. Pfizer Inc Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021) Figure 68. BioLineRx Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021) Figure 69. Genentech Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021) Figure 70. Novo Nordisk Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021) Figure 71. Sanofi Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021) Figure 72. Osiris Therapeutics Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021) Figure 73. Beta-O2 Technologies Ltd Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021) Figure 74. Transition Therapeutics Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021) Figure 75. Bottom-up and Top-down Approaches for This Report Figure 76. Data Triangulation Figure 77. Key Executives Interviewed

ViaCyte PharmaCyte Biotech Boehringer Ingelheim GalaxoSmithKline Beta-Cell NV Novartis Janssen Research & Development Pfizer Inc BioLineRx Genentech Novo Nordisk Sanofi Osiris Therapeutics Beta-O2 Technologies Ltd Transition Therapeutics